About this trial
This study aims to evaluate and compare the children's acceptance of mouthwash containing silver nanoparticles versus Chlorhexidine.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Children aged from 6 to 12 in good general health and medically free
Cooperative patient who will care about attending the follow-up visit
Acceptance of the parents to sign the informed consent
Composite restoration on anterior teeth
Disqualifiers
Children who are unable to attend the follow-up visit
Medically compromised patient
Handi-capped patient
Parents refuse to sign informed consent
Trial design
Parallel
Treatments tested in this trial
nano silver mouthwash
Other interventionnano silver mouthwash will reduce the side effect of chlorhexidine and increase acceptance of the mouthwash to patients
Chlorhexidine mouthwash (0.12%)
Other interventionthe concentration of chlorhexidine
Chlorhexidine mouthwash (0.2%)
Other interventionchlorhexidine mouthwash 0.2% (orovex )
Treatment groups
Trial outcomes
Primary outcomes
children acceptance and compliance
it will be measured by likert scale (1-5) 1 (strongly disagree) 5 (strongly agree)
Secondary outcomes
Gingival health
\* gingival inflammation measured by modified gingival index scoring criteria (0-4) 0 (Normal gingiva ) 4 (sever inflammation of gingiva)
plaque thickness at gingival margin
\* measure plaque thickness at gingival margin by plaque index by loe and silness scoring criteria (0-3) 0 (no plaque) 3 (thick plaque)
color stability of composite restoration of anterior teeth
measure color stability of composite restoration of anterior teeth ΔE\* = √((L₂ - L₁)² + (a₂ - a₁)² + (b₂ - b₁)² Where: L\* = Lightness (0 = black, 100 = white) 1. = Red-Green axis (positive = red, negative = green) 2. = Yellow-Blue axis (positive = yellow, negative = blue * L1, a1, b1 = before exposure * L2, a2, b2 = after exposure A higher ∆E means more discoloration.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: